Leader in the development of permanent seed brachytherapy in the treatment of cancer.

Investor Info

Benefits of Cesium-131

Analyst ReportsInvestor Information - Analyst Coverage

Stephen M. Dunn                                                Matt Kaplan
LifeTech Capital                                                  Managing Director-Healthcare Research
sdunn@lifetechcapital.com                                 Punk Ziegel Healthcare Group
954-240-9968                                                     Ladenburg Thalmann & Co. 
Analyst Reports:                                                 520 Madison Avenue    
02/16/2011 Initiation Report                        New York, NY 10022
06/09/2011 Update Report                          212-891-5247
07/18/2011 Update Report                          Analyst Reports:
10/06/2011 Update Report                          05/17/2011 Ladenburg Research
                                                                           10/04/2011 Update Report
                                                                           11/15/2011 Update Report